4DMedical Limited (ASX: 4DX) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
4DMedical Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
4DMedical Limited (ASX: 4DX)
Latest News
Healthcare Shares
These three biotechs show how the sector can produce huge outsized gains, but are they still good value?
Share Gainers
Why 4DMedical, Regis Resources, Unico Silver, and WiseTech Global shares are pushing higher
Healthcare Shares
This biotech company's shares are on a tear – again – after another contract win
AI Stocks
3 of the fastest-growing stocks on the planet in 2025
Share Fallers
Why 4DMedical, Coronado Global, Metallium, and WiseTech Global shares are falling today
Healthcare Shares
Why 4DMedical shares are jumping 14% today
Share Gainers
Why 4DMedical, Elsight, Judo, and Nickel Industries shares are pushing higher today
Share Fallers
Why 4Medical, Guzman Y Gomez, Lynas, and Predictive Discovery shares are falling today
Share Market News
Why did these ASX shares outperform their peers in 2025?
Share Gainers
Why 4DMedical, Core Lithium, Fenix, and Goodman shares are storming higher today
Opinions
My 5 top stocks to buy in 2026
Share Gainers
Why 4DMedical, Develop Global, EOS, and Maas shares are racing higher today
Frequently Asked Questions
-
No, 4DMedical does not pay dividends at this time.
-
4DMedical listed on the ASX on 7 August 2020.
4DX ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About 4DMedical Limited
4DMedical Ltd (ASX: 4DX) is a medical technology company working in the field of respiratory imaging and ventilation analysis in the treatment of lung and respiratory diseases.
The company's non-invasive lung imaging technology emanates from research work undertaken at Monash University. It is the first FDA-cleared respiratory imaging solution that uses mathematical models and algorithms to convert sequences of X-ray images into four-dimensional quantitative data.
The technology uses existing imaging systems and allows X-ray images to be taken simultaneously from various angles. Using image-processing methods adapted from aerospace engineering, the motion of lung tissue can be measured. This allows ventilation to be calculated at each stage of the breath and at every location within the lung. These measurements are then visualized as a coloured heat map to help medical professionals accurately identify ventilation deficits.
The 4DMedical technology is patented in key jurisdictions, including the US and Australia. The company is aiming to secure a slice of the global lung imaging market. The US market alone was valued at more than $US30 billion in normal pre-COVID diagnostic conditions.
